RICE HALL JAMES & ASSOCIATES, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$11,551,000
-30.6%
114,806
-2.4%
0.43%
-27.9%
Q2 2021$16,651,000
+24.0%
117,649
-12.7%
0.59%
+35.2%
Q1 2021$13,432,000
-20.0%
134,723
-0.8%
0.44%
-25.9%
Q4 2020$16,791,000
-0.5%
135,828
-21.6%
0.59%
-13.1%
Q3 2020$16,882,000
-15.2%
173,292
+35.8%
0.68%
-20.5%
Q2 2020$19,914,000
+36.7%
127,638
+26.5%
0.86%
+5.0%
Q1 2020$14,568,000
-31.7%
100,926
-3.3%
0.81%
+12.7%
Q4 2019$21,332,000
+148.4%
104,349
-2.4%
0.72%
+135.2%
Q3 2019$8,588,000
-16.6%
106,968
-2.0%
0.31%
-10.2%
Q2 2019$10,297,000
+3.9%
109,131
-5.9%
0.34%
+7.2%
Q1 2019$9,908,000115,9180.32%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders